Justice: Foreign Nationals Indicted in Plot to Harass

Justice: Foreign Nationals Indicted in Plot to Harass

Milwaukee and LA juries both indicted foreign nationals (one of China, the other a UK citizen/US permanent resident) with interstate stalking and conspiracy to commit interstate stalking, as well as conspiracy, smuggling, and violations of the Arms Export Control Act. These two people allegedly were harassing a person who criticized actions of China. Starting in 2023, they enlisted people (who were actually FBI, whoops) to prevent the person from protesting Xi's appearance at a summit in 11/2023. They surveilled the person, slashed their tires, and then bought and destroyed statues that the person made that showed Xi and Xi's wife.

Read More

Related Posts

NMFS: Upcoming Import Prohibitions and Industry Webinars

The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…

CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case

Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…

USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology

On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…

FDA: Agency Deploys Agentic AI Capabilities for Staff Use

The U.S. Food and Drug Administration announced the rollout of agency-wide agentic AI tools designed to support employees with complex, multi-step tasks. These systems build on the FDA’s earlier deployment of its LLM-based tool, Elsa-currently used voluntarily by a majority of staff-and introduce more advanced features for workflow automation, planning, and reasoning. Participation remains optional,…